
:: IS CLINIC CERTIFICATION WORTH IT? Documenting and monitoring quality improvement programmes can be costly,
but the benefits are substantial
In 1999, Tobias Neuhann MD invested
more than E20,000 in the future of his
Munich clinic. It wasn't for anything
as tangible as a new laser or diagnostic
device, or construction or even marketing.
Instead, the money - along with a sizable
chunk of his and his staff's time - went
to obtain ISO 9001 certification, making
Augenklinik am Marienplatz the first private
ophthalmic clinic in Bavaria to do so. -
Download pdf here
:: LASER TRABECULOPLASTY - SLT as primary glaucoma therapy
Effective and repeatable, selective
laser trabeculoplasty is gaining
ground as a primary therapy
for mild to moderate primary
open-angle glaucoma (POAG), Garry P
Condon MD, Drexel University College of
Medicine, Pittsburgh, Pennsylvania, US, told
a Glaucoma Day symposium at the ASCRS
annual meeting. -
Download pdf here

:: TAKING CONTROL OF YOUR PRACTICE - The Practice Development programme will give
people an insight into the business of healthcare
The principal focus of the ESCRS has been, and always will be, clinical education
and research. However, there are other aspects to our professional lives which we
ignore at our peril. Health services, whether privately or state funded, need a strong
financial base to survive and provide all the support that our patients deserve. This is
particularly relevant in a fast developing specialty such as ophthalmology, where technological
advancement has been stunning, but which requires rapidly rising funding. -
Download pdf here

:: PREMIUM OFFICE DESIGN- Increasing your office space can create a more complementary setting for patients
Premium office design is an
essential consideration in creating
a premium practice. At a Practice
Development Workshop held
during the 14th ESCRS Winter Meeting, two
leading ophthalmic surgeons described their
experiences of moving into new clinic space
when they outgrew their original facilities. -
Download pdf here
:: PARIS WORKSHOPS - ESCRS helps ophthalmologists learn about
the business of ophthalmology
One of the highlights of the
XXVIII Congress of the
ESCRS in Paris, France will
be the Practice Development
Workshops hosted by EuroTimes. -
Download pdf here

:: AHEAD OF HIS TIME ON LASIK - In 1985 Gholam Peyman filed a patent on stromal ablation under a flap using
an excimer laser, anticipating much of the procedure's future development
Gholam A Peyman MD is perhaps best known
for his pioneering work in vitreo-retinal
surgery, including intravitreal drug delivery,
endoresection, development of the operating
microscope with stereoscopic assistant head, the endolaser
and the first 23-gauge vitrectomy system. While he limits
his clinical practice to retinal diseases, he has developed
techniques and instruments for treating a wide range of
ophthalmic conditions, for which he has been granted 116
US patents. "I felt that I could contribute in management of
the diseases affecting other parts of the eye" he says. -
Download pdf here

:: RUSSIA AND LASIK - Siberian researchers deserve credit for early
proto-LASIK procedure, says excimer laser pioneer
Among the many different
strands of research that together
contributed to the creation of the
LASIK procedure as we know it
today is the little-known work of a Russian
team of ophthalmologists who were the first
to perform an excimer laser ablation on the
stroma beneath a corneal flap. -
Download pdf here
:: CATARACT SURGERY INCREASES RETINAL DETACHMENT RISK - Those at highest risk are young patients, males, myopes, and those who have no PVD
Even with the use of the
most modern and careful
phacoemulsification techniques
in otherwise healthy patients,
cataract surgery carries an elevated risk of
retinal detachment, said Horst Helbig MD,
University Hospital, Regensburg, Germany,
at the 14th ESCRS Winter Meeting. -
Download pdf here
:: PREVENTING ENDOPHTHALMITIS - ESCRS Endophthalmitis Study chairman responds to study's critics
Intracameral cefuroxime still remains
the prophylaxis of choice for the
prevention of endophthalmitis after
cataract surgery, since unlike some
suggested alternatives, its use is supported
by robust data, said Peter Barry FRCS,
St Vincent's University Hospital and
Royal Victoria Eye and Ear Hospital,
Dublin, Ireland. -
Download pdf here
:: CORNEA GENE THERAPY - Experimental applications are promising
The cornea presents unique
opportunities and challenges
for gene therapy with potential
applications ranging from treating
dystrophies to reducing haze after surface
ablation, reported Mark Rosenblatt MD, PhD
at the Sixth World Cornea Congress. -
Download pdf here




eTIMES newsletter
eTIMES is a new bi-monthly newsletter with the latest breaking news from the ESCRS and the world of ophthalmology.
Media Guide 2010
Results from our readership survey plus information about advertising in EuroTimes
Podcasts
Eye Contact features interviews with key opinion leaders in the world of ophthalmology
Friday, 03 September 2010
www.eurotimes.org